VT
Voyager Therapeutics Inc
🇺🇸XNAS.VYGRUnited StatesHealthcare
$3.03USDdown -0.07 (-2.26%)OpenDelayed3:25 PM
Price$3.03-0.07 (-2.26%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US92915B1061
- CUSIP
- 92915B106
Company
- Employees
- 141
- Headquarters
- Lexington, United States
- CEO
- Ms. Trista Morrison
Market
- Shares outstanding
- 61.6M
- Market cap
- $186.7M
Highlights
- Market cap
- $190.4M
- EPS LTM
- -$1.78
- P/E LTM
- -1.98
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $34.46M-19.07%down year on year
- Net income
- -$107.73M+0.19%up year on year
- Gross margin
- -104.16%+46.77%up year on year
- Free cash flow
- -$121.42M-4.83%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.